North America - United States • International trade

Latham & Watkins LLP

More informationMore information

Housing a formidable CFIUS practice, Latham & Watkins LLP secured key roles on a host of high-profile reviews over the past year. The group’s success is due in no small part to its strong combination of standalone national security expertise together with its ability to service clients from top-tier offerings across the firm, including M&A, energy, life sciences and TMT. Widely acknowledged to rank among the market leaders for CFIUS matters, Damara Chambers co-heads the CFIUS and US national security department; she recently represented Consolidated Edison in obtaining clearance for the sale of its interest in its wholly owned subsidiary, Con Edison Clean Energy Businesses and its subsidiaries, to RWE Renewables Americas. Les P. Carnegie co-leads the Washington-based CFIUS and US national security practice and represents a broad range of companies, financial institutions and private equity funds on security reviews. Rounding out the senior partners is global chair of the connectivity industry group, James Barker, who has extensive experience in CFIUS and Team Telecom matters. The practice additionally draws on a strong second line of non-partners, including new counsel Catherine Hein, who joined in May 2023 from the USDT; counsel Ruchi Gill, who formerly served as Deputy Chief Counsel for the US Senate Committee on Foreign Relations; and Zachary Eddington, who was promoted to counsel in early 2024.

Legal 500 Editorial commentary

Key clients

  • Consolidated Edison
  • LG Chem
  • Opiant Pharmaceuticals
  • Hyundai Motor Company (South Korea)
  • Viasat
  • DB Schenker

Work highlights

  • Represented Consolidated Edison in obtaining clearance from CFIUS for the sale of its interest in its wholly owned subsidiary, Con Edison Clean Energy Businesses and its subsidiaries, to RWE Renewables Americas LLC.
  • Represented LG Chem in securing CFIUS clearance for its acquisition of AVEO Oncology.
  • Represented Opiant Pharmaceuticals in receiving clearance from CFIUS for its acquisition by Indivior.

Lawyers

Leading lawyers

Practice head

The lawyer(s) leading their teams.

Les Carnegie, Damara Chambers, James Barker

Other key lawyers

Catherine Hein, Ruchi Gill, Zachary Eddington